NH

National Health Investors, Inc.

NHIReal EstateNASDAQ

REIT - Healthcare Facilities

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$375.6M
+12.1% YoY
Net Income
$142.2M
+3.0% YoY
EBITDA
$275.7M
+4.3% YoY
Free Cash Flow
$172.0M

Scan Results

Daily timeframe
DateIndicatorDetails
Sep 2 MACD Negative CrossoverHistogram -0.0604, negative momentum
Sep 1 MACD Negative CrossoverHistogram -0.0988, negative momentum
About National Health Investors, Inc.

National Health Investors, Inc. is a self-managed real estate investment trust (REIT). With a market capitalization of $3.48B, it sits in mid-cap territory. The Company owns, leases, operates and finances the development of high-quality real estate properties in the United States, focusing on senior housing communities and medical facilities.

Where NHI stands vs its 150-day and 200-day moving averages

As of the September 2, 2026 close, NHI finished 7.13% below its 150-day moving average ($77.82) and 6.52% below its 200-day moving average ($77.31). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is NHI overbought or oversold?

At the September 2, 2026 close, NHI's RSI(14) was 59.1, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$3.48B
P/E (TTM)20.49
Fwd P/E21.83
EPS$3.46
Beta0.55
52W Change-9.7%
Dividend Yield5.30%
ROE10.7%
Analysis

National Health Investors, Inc. carries $1.52B in total debt against $113.4M in cash reserves — debt is roughly 13.4x the cash position. Managing this leverage effectively will be important for long-term financial stability. The company generates $172.0M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 10.7% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 4.4% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $278.2M (2022) to $375.6M (2025), reflecting a 35% increase over the period.

NHI's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. National Health Investors, Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. No single metric tells the full story. Reviewing NHI's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Real Estate stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms